Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ACOT1	"ACH2, CTE-1, LACH2"	ENSG00000184227	"Acyl-CoA thioesterase 1"	Q86TX2	14	73537114-73543794	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 27.6"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 18.2;T-47d: 25.1"									HPA043705	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA043705: AB_2678626"	"unprognostic (4.74e-3)"	"unprognostic (3.81e-3)"	"unprognostic (7.65e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.16e-1)"	"prognostic favorable (5.09e-8)"	"unprognostic (1.35e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.43e-1)"	8.5	7.2	5.1	3.7	3.9	1.0	13.7	2.0	7.7	3.0	5.8	4.1	0.9	5.3	6.8	8.8	2.7	3.4	1.8	11.3	4.3	3.6	16.4	27.6	9.0	0.9	3.2	6.0	4.5	1.4	2.9	0.9	4.1	5.6	5.5	3.4	2.4	2.7	6.1	10.7	3.8	12.9	13.0	1.9	1.0	3.4	2.7	2.4	0.9	1.8	5.0	1.9	5.6	1.7	3.8	5.7	1.0	1.7	4.2	6.3	3.1	4.2	5.0	1.9	0.1	9.9	6.1	0.1	1.3	5.4	4.5	8.2	1.9	2.1	0.0	0.0	3.6	0.0	2.5	0.0	0.9	2.2	2.3	1.6	2.7	1.2	18.2	9.6	0.1	3.0	7.9	0.4	3.6	0.0	0.1	2.0	0.0	0.0	0.0	3.5	1.6	0.3	0.5	1.9	0.6	1.9	5.1	3.9	0.1	4.4	4.7	2.3	3.8	4.2	12.4	6.8	0.4	25.1	6.2	2.2	2.5	3.2	2.3	0.0	0.0	0.0	1.3	3.6	0.0	4.0	0.1	1.3	1.0	6.0	1.7	4.9	3.8	5.5	4.7	5.7	2.6	4.8	5.3	0.2	4.2	1.5	3.2	6.3	3.1	5.1	3.9	2.0	7.7	4.3	3.6	3.2	6.0	5.6	2.4	0.0	2.7	0.0	0.0	0.0	0.0	44.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.4	0.0	0.0	0.0	7.2	0.2	0.3	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.7	0.0	0.4	0.8	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.0
ACOT6	C14orf42	ENSG00000205669	"Acyl-CoA thioesterase 6"	Q3I5F7	14	73610945-73619888	"Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 6.8;liver: 6.1;skeletal muscle: 6.5"	"Cell type enhanced"	"Detected in some"	21	"Hepatocytes: 2.4;Proximal tubular cells: 2.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"T-47d: 15.3"									HPA058258	Uncertain					NA	NA					"HPA058258: AB_2683656"	"unprognostic (1.88e-1)"				"unprognostic (1.77e-1)"		"unprognostic (5.17e-2)"	"unprognostic (1.24e-1)"		"unprognostic (3.15e-2)"		"unprognostic (6.52e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.07e-2)"		"unprognostic (2.28e-1)"	"unprognostic (5.04e-1)"	2.6	1.0	1.5	0.0	2.0	0.0	0.1	0.8	1.2	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.8	0.6	6.8	6.1	0.0	0.0	0.8		0.7	0.4	0.0	0.0	0.0		0.0	0.0		0.0	0.0	6.5	0.0	0.0	0.0	0.2	0.1	0.0	0.9			1.4		0.0	0.0	0.0	0.1	1.8	0.0	0.6	0.0	1.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.0	1.0	2.8	0.1	0.0	15.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.1	0.8	1.8	0.1	0.3	0.8	0.0	0.0	0.0	0.2	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
ACSL1	"ACS1, FACL1, FACL2, LACS, LACS1, LACS2"	ENSG00000151726	"Acyl-CoA synthetase long chain family member 1"	P33121	4	184755595-184826818	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 105.0;liver: 190.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 359.4;Hepatocytes: 1018.8;Late spermatids: 335.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"neutrophil: 80.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 80.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 151.2;ASC TERT1: 36.7;HSkMC: 80.3;RPTEC TERT1: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011316, HPA011964"	Enhanced		Uncertain	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Nucleoplasm	"Mitochondria, Cytosol"	"HPA011316: AB_1844536, HPA011964: AB_1844537"	"unprognostic (1.10e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.89e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (2.77e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (3.13e-2)"	105.0	6.7	4.2	14.1	13.5	46.0	54.4	3.2	9.6	7.2	12.2	16.4	5.5	4.9	5.7	12.7	8.8	6.4	5.7	24.3	6.4	4.1	32.8	190.9	20.7	18.9	24.0	3.8	4.2	7.3	5.9	8.7	4.4	11.6	14.2	2.6	9.1	17.9	4.8	89.1	20.4	4.5	6.4	18.2	16.9	6.5	6.4	15.9	2.1	8.3	10.1	5.8	7.6	11.0	0.5	2.2	80.2	8.9	0.7	0.7	2.9	6.1	1.9	1.2	3.1	151.2	36.7	1.0	3.4	1.7	2.0	1.4	0.4	1.7	2.5	0.3	4.0	4.9	3.8	5.4	2.2	1.7	12.4	1.9	1.8	1.7	5.0	24.3	4.9	4.6	80.3	18.6	1.7	8.7	3.6	2.6	0.4	0.8	7.8	9.8	3.2	0.3	6.8	0.2	4.1	2.7	0.9	1.0	3.2	47.8	17.5	4.6	4.3	3.1	9.4	10.5	0.5	3.4	5.0	2.8	1.8	2.1	4.3	1.0	3.0	1.5	1.1	5.8	6.9	2.8	2.3	8.9	2.8	0.5	5.2	0.5	0.5	0.4	0.2	2.2	0.5	0.4	0.3	80.2	0.7	3.6	0.4	0.7	2.9	4.2	13.5	3.2	9.6	6.4	4.1	24.0	3.8	11.6	15.9	23.8	107.2	14.5	16.5	18.7	5.8	89.7	28.1	13.4	21.6	29.6	17.7	8.6	79.6	3.9	359.4	5.6	2.6	0.0	11.0	1.9	9.1	56.1	23.1	1018.8	39.4	3.2	0.0	19.0	136.2	335.5	17.8	64.1	30.4	24.4	4.2	3.3	9.0	0.9	15.6	75.0	10.3	12.9	12.0	8.1	16.7	35.9	2.9	10.0	1.7	21.4
ACSL3	"ACS3, FACL3, PRO2194"	ENSG00000123983	"Acyl-CoA synthetase long chain family member 3"	O95573	2	222860934-222944639	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 206.1"	"Cell type enhanced"	"Detected in all"	9	"Horizontal cells: 494.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 94.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011315, HPA071021"	Approved		Approved	"Nucleoli,Nucleoli rim,Lipid droplets"		NA	NA			"Nucleoli, Nucleoli rim"	"Lipid droplets"	"HPA011315: AB_1848344, HPA071021: AB_2686335"	"unprognostic (1.87e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.35e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (2.75e-4)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (3.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.60e-1)"	14.7	17.0	22.8	9.9	26.0	16.3	51.5	19.4	45.9	15.3	16.5	16.1	11.6	12.7	10.9	18.4	28.3	9.0	11.8	22.7	20.9	22.8	17.9	22.3	15.6	10.5	19.6	21.2	11.7	10.3	206.1	8.8	19.1	24.4	44.4	16.7	14.4	34.2	15.5	19.1	11.4	12.7	12.2	22.2	9.7	28.3	13.7	14.2	13.5	17.3	11.2	8.7	14.6	15.4	15.0	22.5	21.8	16.8	16.6	20.1	16.5	10.1	17.9	27.4	29.8	12.0	29.8	7.6	12.9	33.6	15.5	32.7	16.1	26.1	4.8	7.5	12.3	33.5	29.9	5.9	28.7	20.1	8.7	11.2	11.4	14.5	17.9	26.5	7.5	5.6	15.3	40.8	25.6	44.7	11.9	16.8	8.5	21.5	18.6	21.8	21.5	14.6	8.8	13.9	23.0	9.3	8.0	23.2	8.2	22.3	41.6	14.5	10.7	7.6	20.6	94.2	22.1	10.3	18.4	11.6	10.4	16.6	8.9	9.4	6.6	3.2	16.8	11.1	7.1	31.4	16.6	14.6	21.8	20.1	16.8	19.3	11.6	12.8	14.6	15.7	15.0	18.7	16.7	21.8	16.6	15.9	22.5	9.5	16.5	22.8	26.0	19.4	45.9	20.9	22.8	19.6	21.2	24.4	14.2	32.8	58.5	16.4	65.8	41.3	91.7	51.2	40.8	37.5	44.3	34.9	72.6	32.9	6.6	28.6	31.0	38.3	33.1	23.3	27.3	8.4	36.3	113.5	26.5	47.9	33.5	494.2	20.1	36.2	50.2	18.9	24.2	42.9	45.5	32.5	32.3	205.8	32.5	38.6	33.6	12.5	51.8	45.3	51.8	50.2	49.9	42.7	50.7	27.7	46.5	102.1
ACSL4	"ACS4, FACL4, LACS4, MRX63, MRX68"	ENSG00000068366	"Acyl-CoA synthetase long chain family member 4"	O60488	X	109624244-109733403	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Alport syndrome, Deafness, Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Alveolar cells type 2: 210.9;granulocytes: 598.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 81.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000286, HPA005552"	Supported		Approved	"Golgi apparatus,Mitochondria"		NA	NA		100000	"Golgi apparatus"	Mitochondria	"HPA000286: AB_2665966, HPA005552: AB_1078774"	"unprognostic (9.13e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.94e-2)"	"unprognostic (5.32e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.29e-2)"	"prognostic favorable (5.73e-4)"	29.5	31.1	16.3	25.5	18.0	9.2	30.0	13.9	22.8	34.7	10.5	8.8	4.6	10.0	13.7	11.7	11.2	10.7	20.1	20.3	27.6	20.3	31.2	9.6	27.8	29.6	15.2	19.0	13.1	8.8	16.7	12.9	33.9	21.1	9.7	9.7	8.0	10.7	11.0	42.5	9.1	9.0	15.8	24.6	17.0	12.9	17.7	9.7	9.5	12.8	8.5	11.9	19.5	21.0	2.2	6.5	20.3	10.9	2.2	4.0	3.8	13.9	4.5	5.6	6.0	21.1	13.2	4.4	20.5	22.7	20.0	20.9	4.4	9.7	10.0	8.0	14.8	24.6	4.0	4.8	19.7	31.6	3.5	5.0	39.4	6.4	46.6	9.7	9.3	81.7	11.4	7.7	22.8	16.7	11.6	15.0	6.4	1.1	12.3	22.9	0.9	8.1	12.3	7.0	3.1	8.2	5.9	10.3	8.2	28.7	4.5	3.7	2.8	24.5	0.0	12.6	11.5	0.3	10.0	27.7	18.3	5.2	28.9	18.8	6.1	7.0	9.4	32.3	20.9	11.6	15.5	7.0	20.3	2.8	9.8	2.0	2.2	2.5	2.2	6.5	2.2	2.0	2.4	19.8	2.2	10.9	2.6	4.0	3.8	16.3	18.0	13.9	22.6	27.6	20.3	15.2	19.0	21.1	9.7	71.5	210.9	20.6	16.2	19.8	34.7	32.3	10.2	17.4	64.8	69.8	2.0	5.7	43.1	24.1	1.2	28.6	0.7	23.3	22.2	29.6	17.9	10.6	598.2	1.7	22.2	6.4	7.5	17.8	68.3	2.0	5.2	45.1	15.1	64.9	2.9	11.7	26.4	1.4	9.6	10.0	14.5	0.0	22.3	3.9	3.8	7.0	26.4	13.8	1.7	12.4
ACSL5	"ACS2, ACS5, FACL5"	ENSG00000197142	"Acyl-CoA synthetase long chain family member 5"	Q9ULC5	10	112374018-112428380	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 278.7"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 266.6;Paneth cells: 93.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.3;RT4: 44.2;U-937: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007162, CAB035986, CAB062546"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		22000	Mitochondria	Nucleoplasm	"CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.08e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.08e-3)"	10.0	1.4	3.1	12.7	3.5	2.2	6.4	1.2	3.1	9.3	84.6	1.6	3.8	64.5	8.7	41.8	4.2	8.0	11.2	3.1	3.3	3.1	3.2	56.5	10.8	7.1	4.0	1.2	5.0	1.6	0.1	1.2	2.1	3.9	7.0	21.5	8.4	2.4	4.0	2.6	1.3	278.7	2.6	3.8	12.4	7.7	2.3	2.5	6.3	3.1	2.7	7.2	17.4	6.7	10.8	19.4	16.3	17.0	16.2	25.1	11.7	11.6	0.3	0.2	0.0	0.8	0.1	1.0	0.3	2.3	0.0	0.2	10.6	43.3	14.2	2.6	0.6	2.1	0.1	0.0	0.0	0.2	11.9	0.0	11.1	0.4	18.5	2.8	17.2	18.8	1.9	0.0	0.2	0.0	0.8	0.8	0.0	0.0	6.5	0.0	0.0	0.0	7.9	0.0	9.8	0.4	3.9	0.0	8.7	1.2	44.2	0.0	0.3	17.3	6.6	0.0	0.0	0.0	9.7	12.5	0.1	0.1	0.7	0.7	4.7	0.0	6.9	0.4	21.6	0.0	14.5	9.3	16.3	16.7	17.0	16.6	10.8	13.7	18.4	19.4	8.2	9.5	14.5	2.5	16.2	15.9	6.2	25.1	11.7	3.1	3.5	1.2	3.1	3.3	3.1	4.0	1.2	3.9	2.5	11.9	43.5	21.6	7.4	3.4	0.0	1.4	12.7	5.3	33.0	0.0	3.9	1.6	0.0	12.0	65.8	24.5	266.6	0.0	5.6	1.9	1.7	5.7	17.3	79.9	16.7	0.0	39.2	16.0	19.2	29.7	14.7	23.5	3.3	4.6	84.3	0.0	29.0	93.1	11.3	0.0	1.2	0.0	1.4	1.7	1.4	1.5	0.6	14.9	90.6	41.4
ACSL6	"ACS2, FACL6, KIAA0837, LACS2, LACS5"	ENSG00000164398	"Acyl-CoA synthetase long chain family member 6"	Q9UKU0	5	131949973-132012243	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.0;ductus deferens: 30.1;seminal vesicle: 35.8;testis: 23.0"	"Cell type enhanced"	"Detected in many"	14	"Cone photoreceptor cells: 216.0;Erythroid cells: 116.8;Rod photoreceptor cells: 126.2"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 14.9;U-937: 8.7"									HPA040470	Enhanced					NA	NA					"HPA040470: AB_10794033"	"unprognostic (1.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.89e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.38e-3)"	"unprognostic (5.84e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.57e-2)"	"unprognostic (9.28e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.70e-1)"	0.6	4.8	16.5	1.5	15.7	21.3	0.7	22.8	34.0	0.5	0.7	5.3	30.1	5.4	0.5	1.0	0.9	0.7	0.9	2.0	12.4	9.7	2.3	2.6	0.8	2.5	9.6	12.1	0.5	1.9	13.0	2.7	1.1	12.1	0.8	0.8	3.3	0.8	35.8	3.6	0.6	3.3	0.5	4.2	1.2	1.2	23.0	4.7	0.0	0.9	0.0	1.5	0.7	0.3	0.1	0.0	0.6	0.1	1.2	4.2	1.1	0.0	0.0	0.3	0.1	0.6	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.5	0.1	1.6	0.2	0.0	0.0	0.9	0.1	0.0	2.2	0.0	0.2	2.1	0.0	0.1	0.0	0.1	0.0	0.0	2.1	1.0	0.2	0.0	0.0	0.0	1.5	0.9	0.0	0.1	0.1	0.0	0.1	0.0	0.0	14.9	0.7	0.2	0.2	1.2	0.5	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.5	0.0	0.3	8.7	0.5	0.6	0.1	0.1	1.5	0.0	3.5	0.1	2.1	4.2	0.0	0.1	3.9	1.8	0.2	1.2	0.0	0.0	0.1	1.1	16.5	15.7	22.8	18.8	12.4	9.7	9.6	12.1	12.1	4.7	23.8	33.5	0.5	1.0	1.6	55.8	0.0	2.5	14.7	29.6	1.8	216.0	0.3	6.6	0.4	22.7	0.4	0.7	116.8	0.2	0.2	1.1	1.0	9.3	5.7	0.1	20.6	2.4	2.5	1.2	3.6	0.3	7.9	0.0	0.0	0.6	20.4	0.2	0.9	1.8	0.3	126.2	0.0	0.8	16.1	1.3	1.1	0.2	10.7	0.2	0.9
ALOX12B	12R-LOX	ENSG00000179477	"Arachidonate 12-lipoxygenase, 12R type"	O75342	17	8072636-8087703	"Disease related genes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skin 1: 38.9;tongue: 55.3"	"Cell type enhanced"	"Detected in some"	11	"Horizontal cells: 1.6;Rod photoreceptor cells: 1.1;Suprabasal keratinocytes: 1.6"	"Group enriched"	"Detected in many"	9	"cervical cancer: 2.6;head and neck cancer: 11.2;melanoma: 4.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"basophil: 7.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.0"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.2;hTCEpi: 3.6;JURKAT: 6.7;OE19: 3.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA024002	Supported		Supported	Cytosol		NA	NA			Cytosol		"HPA024002: AB_1844757"	"unprognostic (1.27e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.18e-2)"		"unprognostic (1.26e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.66e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.46e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	1.1	0.1	0.3	7.7	0.1	0.1	0.1	0.1	0.5	0.1	3.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.1	0.6	38.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	55.3	11.4	0.1	6.2	0.9	0.2	7.0	0.0	0.2	1.1	0.2	1.2	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.2	0.0	1.0	0.5	0.2	0.2	0.0	0.0	3.2	0.0	0.9	0.2	0.0	0.5	0.0	0.0	3.6	0.2	0.6	0.1	0.0	6.7	0.0	0.0	0.0	0.1	0.3	0.0	0.6	3.8	0.3	2.3	0.0	0.9	0.4	0.0	1.0	1.4	0.2	0.2	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	2.3	0.1	0.0	0.0	0.0	7.0	0.0	0.0	0.5	0.0	0.7	0.9	0.3	0.5	0.0	0.3	1.1	1.0	0.0	0.2	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.9	0.4	1.6	0.0	0.0	0.0	0.0
ALOX5	5-LOX	ENSG00000012779	"Arachidonate 5-lipoxygenase"	P09917	10	45374176-45446119	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Leukotriene biosynthesis"	"Dioxygenase, Hydrolase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 45.2;bone marrow: 39.9;lymphoid tissue: 41.8"	"Cell type enhanced"	"Detected in many"	13	"granulocytes: 194.3;Hofbauer cells: 78.7;Kupffer cells: 81.6;Macrophages: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;CAPAN-2: 6.1;Daudi: 22.3;HMC-1: 16.0;Karpas-707: 7.0;RT4: 10.5;U-266/70: 10.5;U-698: 7.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071285	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA071285: AB_2686379"	"unprognostic (2.57e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (7.18e-4)"	7.4	3.9	2.9	18.3	7.4	39.9	5.8	13.2	3.2	3.4	6.5	6.4	1.0	4.5	3.2	4.7	4.9	5.4	8.0	6.1	3.9	2.6	4.8	2.6	34.7	36.9	9.0	1.7	2.6	10.0	1.3	1.7	11.2	6.1	7.8	3.4	3.2	6.6	3.4	1.1	2.9	14.4	7.8	8.4	41.8	4.5	2.0	6.2	2.4	3.0	1.4	16.7	27.2	10.5	14.8	11.1	45.2	21.3	0.0	0.5	9.5	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	6.1	22.3	0.8	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.2	4.3	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	0.8	0.3	10.5	0.5	0.0	0.0	0.2	0.0	0.1	0.1	0.5	0.0	0.0	1.2	0.0	0.0	10.5	1.9	7.4	0.0	0.1	0.0	36.7	21.3	27.0	0.0	20.0	0.1	14.8	0.5	0.2	11.1	10.4	0.0	0.0	45.2	0.0	19.6	0.3	0.1	9.5	2.9	7.4	13.2	3.2	3.9	2.6	9.0	1.7	6.1	6.2	14.9	58.3	34.9	5.4	1.0	0.8	2.0	15.3	4.0	12.5	8.7	2.0	0.5	0.0	19.2	0.4	0.7	2.1	0.0	18.9	1.4	0.6	3.3	194.3	0.6	78.7	0.0	6.8	2.5	81.6	1.1	0.3	81.2	0.0	18.0	0.7	0.3	17.8	0.0	0.0	0.0	0.2	12.9	0.7	0.4	0.8	1.3	3.4	1.3	0.4	35.5
BAAT	BAT	ENSG00000136881	"Bile acid-CoA:amino acid N-acyltransferase"	Q14032	9	101360417-101383519	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Serine esterase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 128.4"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 745.7"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 181.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.1;CACO-2: 3.4;Hep G2: 2.4;OE19: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021251, HPA021330"	Enhanced		Uncertain	Vesicles		NA	NA		470000	Vesicles		"HPA021251: AB_1845247, HPA021330: AB_2670674"	"unprognostic (2.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.97e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.68e-2)"	"prognostic favorable (4.97e-4)"	"unprognostic (2.14e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.24e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.8	0.0	0.1	0.1	0.2	128.4	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.2	0.0	0.7	0.1	0.1	6.1	0.4	0.3	0.0	0.0	0.0	0.3	0.1	0.1	0.3	3.4	0.1	0.6	0.2	0.0	0.3	0.3	0.1	0.2	0.5	0.3	0.1	0.5	0.2	2.4	0.0	0.9	0.3	0.0	1.0	0.1	0.0	0.1	0.0	0.8	0.7	0.4	0.5	0.1	0.2	0.3	1.0	2.6	0.7	0.2	1.1	0.2	0.6	0.2	0.3	0.4	0.4	0.2	0.5	0.2	0.0	0.2	0.1	0.6	0.6	0.2	0.4	0.4	0.6	0.5	0.5	0.2	0.6	0.3	0.2	0.0	0.7	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.8	0.4	89.2	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	745.7	0.0	0.0	0.0	11.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CBR1	"CBR, SDR21C1"	ENSG00000159228	"Carbonyl reductase 1"	P16152	21	36069941-36073166	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 176.1"	"Cell type enhanced"	"Detected in all"	8	"Distal tubular cells: 641.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA018433, CAB034291"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		12000000	Nucleoplasm	Cytosol	"CAB034291: AB_2070856, HPA018433: AB_1846109"	"prognostic favorable (2.18e-4)"	"unprognostic (9.78e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.00e-1)"	"prognostic favorable (4.75e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.47e-2)"	9.6	22.9	31.7	8.4	41.6	3.7	8.5	12.0	35.8	14.6	63.4	75.9	6.5	176.1	9.3	17.1	40.2	9.6	15.1	7.8	37.7	24.7	35.2	77.2	11.7	8.5	57.3	25.2	10.4	8.0	8.9	7.9	11.7	51.6	16.7	16.8	10.4	23.1	15.0	8.7	34.4	118.1	11.6	48.1	10.0	41.4	5.7	41.9	3.6	11.3	29.8	14.3	12.4	17.1	17.0	29.9	17.1	51.4	19.1	29.2	37.0	25.3	39.1	4.8	12.3	25.1	25.4	0.2	28.5	20.5	15.6	18.7	14.4	14.9	6.4	18.8	26.5	30.1	18.7	9.8	27.9	12.0	31.5	23.1	19.1	22.8	9.8	14.4	10.6	17.6	12.4	35.2	15.1	6.6	17.9	16.6	0.0	0.0	4.7	14.3	25.1	5.3	11.1	0.0	0.0	28.6	0.0	0.1	17.7	41.4	12.7	14.0	12.5	27.5	40.0	32.4	3.9	18.9	14.8	16.7	17.5	7.4	44.3	20.6	32.0	57.9	0.1	32.1	10.6	25.3	1.8	36.6	17.1	18.1	51.4	15.3	17.0	22.7	16.9	29.9	15.6	29.2	21.4	2.5	19.1	38.6	10.4	22.7	37.0	31.7	41.6	12.0	35.8	37.7	24.7	57.3	25.2	51.6	41.9	113.2	54.7	13.0	59.4	113.9	11.9	19.9	81.5	111.1	96.7	90.7	2.0	102.1	641.6	73.2	5.9	17.8	131.2	46.7	60.9	77.8	54.3	48.6	34.6	203.8	78.0	3.2	37.1	54.6	65.5	2.9	113.6	47.2	86.0	102.8	58.6	65.5	81.3	71.8	124.5	200.8	7.4	25.8	60.8	4.2	11.3	108.0	74.6	30.9	77.6	42.0
CBR3	SDR21C2	ENSG00000159231	"Carbonyl reductase 3"	O75828	21	36134912-36146566	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 68.2"	"Group enriched"	"Detected in many"	4	"Basal glandular cells: 23.4;Basal keratinocytes: 63.1;Glandular cells: 36.1;Leydig cells: 62.7;Melanocytes: 62.4;monocytes: 36.1;Peritubular cells: 71.1;Smooth muscle cells: 20.3;Suprabasal keratinocytes: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 11.9;NK-cells: 4.9;T-cells: 17.9"	"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 43.6"	"Low region specificity"	"Detected in all"			HPA018434	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	NA			"Nucleoplasm, Cytosol"		"HPA018434: AB_1846110"	"unprognostic (3.64e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.75e-1)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (5.95e-6)"	"unprognostic (3.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.94e-1)"	9.2	1.5	5.4	3.0	13.9	0.9	12.2	3.1	4.7	8.6	3.8	1.4	4.1	2.4	5.5	8.8	27.6	4.1	4.9	4.9	3.6	2.9	1.6	0.4	3.5	3.4	3.8	6.1	9.3	1.2	0.3	1.2	2.2	2.5	7.2	2.9	3.3	21.8	4.2	2.4	16.3	2.6	10.5	2.3	1.5	2.7	4.3	2.7	0.9	2.3	68.2	14.1	7.1	8.0	11.9	1.2	0.4	0.5	4.9	17.9	6.2	12.2	3.5	1.5	3.1	12.0	18.6	2.4	13.4	15.9	15.4	12.3	0.1	2.6	0.0	3.9	13.7	5.4	5.7	2.0	2.7	6.2	16.7	6.4	0.5	3.7	0.1	1.0	0.0	0.0	2.6	0.3	10.7	1.4	7.4	9.3	1.4	0.0	0.1	4.5	9.2	1.1	5.4	1.2	3.8	15.5	2.6	2.9	23.9	5.1	5.2	0.8	1.1	10.2	12.5	19.5	0.8	3.7	1.4	6.4	10.0	0.8	11.2	12.9	0.6	0.2	0.0	10.4	0.3	17.9	0.0	0.3	0.0	1.2	0.2	1.5	11.9	13.0	4.0	1.2	10.6	17.9	12.3	0.4	4.9	0.5	0.3	5.1	6.2	5.4	13.9	3.1	4.7	3.6	2.9	3.8	6.1	2.5	2.7	0.0	2.7	0.0	23.4	63.1	0.2	0.2	5.1	5.3	11.4	0.0	0.0	0.9	8.3	3.3	0.5	11.3	1.1	0.0	0.6	0.2	7.7	36.1	5.7	0.0	7.4	0.0	0.0	8.6	3.7	1.1	62.7	5.6	62.4	36.1	8.9	1.4	2.1	1.1	71.1	0.0	0.4	0.0	20.3	0.4	0.2	40.8	0.2	1.3	2.9	11.5
CYP2F1	CYP2F	ENSG00000197446	"Cytochrome P450 family 2 subfamily F member 1"	P24903	19	41114432-41128366	"Enzymes, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lung: 10.4;lymphoid tissue: 6.1;pituitary gland: 4.6;testis: 4.9"	"Cell type enhanced"	"Detected in some"	29	"Ciliated cells: 22.7;Club cells: 48.9;Spermatocytes: 9.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.6"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 7.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA						"unprognostic (2.04e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.29e-3)"		"unprognostic (6.23e-3)"		"unprognostic (2.87e-2)"	"unprognostic (3.91e-2)"		"unprognostic (1.58e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.50e-1)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	3.1	6.1	0.0	2.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	22.7	48.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	4.8	0.0	0.0	0.0	0.0	0.0
CYP4F12		ENSG00000186204	"Cytochrome P450 family 4 subfamily F member 12"		19	15672757-15697174	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"intestine: 53.0;liver: 24.2"	"Cell type enhanced"	"Detected in many"	16	"Enterocytes: 95.3;Paneth cells: 35.4;Undifferentiated cells: 26.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	39	"basophil: 5.3;eosinophil: 13.2"	"Lineage enriched"	"Detected in single"	76	"granulocytes: 13.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.6;HaCaT: 18.7;Hep G2: 5.2;Karpas-707: 12.6;OE19: 27.1"									HPA058960	Approved					NA	NA					"HPA058960: AB_2683862"	"unprognostic (4.30e-4)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.32e-3)"	"unprognostic (1.84e-3)"	"unprognostic (9.13e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.20e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (2.33e-4)"	1.9	0.7	1.6	6.1	0.9	0.6	3.5	0.0	1.9	3.9	24.6	5.6	1.4	24.6	1.4	1.8	11.5	2.1	10.8	1.7	1.9	0.3	1.1	24.2	0.9	0.3	3.0	3.5	1.9	0.2	0.1	0.3	0.4	2.7	4.4	5.1	1.4	3.0	1.5	0.4	12.9	53.0	5.1	0.8	0.7	8.0	0.4	4.8	0.2	0.6	8.9	6.3	10.1	6.5	0.0	0.0	13.2	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.3	0.0	0.0	0.1	18.7	0.0	0.0	0.0	1.0	0.0	0.0	0.7	5.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.3	0.0	13.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.0	1.9	1.9	0.3	3.0	3.5	2.7	4.8	0.0	2.6	0.8	10.1	12.5	0.0	1.0	5.1	2.7	0.0	0.0	0.0	0.1	0.0	0.3	1.1	1.5	95.3	0.0	0.0	0.1	3.0	2.8	0.0	24.2	0.4	0.0	7.5	0.6	0.3	2.2	3.7	0.0	1.7	0.0	24.4	2.7	1.1	35.4	1.1	2.1	0.0	0.0	0.8	0.1	0.0	18.4	0.2	0.7	26.0	18.3
CYP4F2		ENSG00000186115	"Cytochrome P450 family 4 subfamily F member 2"	P78329	19	15878023-15898120	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 69.1;liver: 102.9"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 132.0"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 29.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"basophil: 8.5"	"Lineage enriched"	"Detected in single"	86	"granulocytes: 8.5"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 9.0"									"HPA014048, HPA017265, HPA058960"	Supported				"Intracellular and membrane"	NA	NA					"HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: AB_2683862"	"unprognostic (7.46e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.55e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.89e-1)"		"unprognostic (7.79e-3)"	0.1	0.1	0.2	0.5	0.1	0.0	0.2	0.1	0.2	0.2	10.1	0.2	0.1	24.5	0.1	8.8	0.2	0.1	1.8	0.1	0.2	0.1	11.9	102.9	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.2	1.9	0.0	0.1	0.1	0.2	0.1	0.5	69.1	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.4	0.3	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.7	0.1	0.3	0.1	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.2	9.0	0.0	1.0	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	1.6	0.1	0.0	0.1	0.3	0.6	0.8	0.1	0.4	0.4	0.9	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.5	5.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	6.2	0.0	16.2	0.0	0.3	0.0	0.0	0.6	0.0	132.0	0.0	0.0	1.7	0.6	3.9	11.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	5.8	0.0	14.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	3.0	0.1
CYP4F22	FLJ39501	ENSG00000171954	"Cytochrome P450 family 4 subfamily F member 22"	Q6NT55	19	15508493-15552317	"Disease related genes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	Ichthyosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 44.6;skin 1: 29.0"	"Cell type enhanced"	"Detected in some"	21	"Glandular cells: 1.9;granulocytes: 6.9;Spermatogonia: 1.5;Suprabasal keratinocytes: 2.6"	"Group enriched"	"Detected in many"	7	"breast cancer: 4.5;head and neck cancer: 5.7;liver cancer: 8.5;melanoma: 4.5;urothelial cancer: 13.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 6.1;MAIT T-cell: 4.6;non-classical monocyte: 13.2"	"Group enriched"	"Detected in many"	9	"monocytes: 13.2;T-cells: 4.6"	"Cell line enhanced"	"Detected in some"		"HEL: 1.3;JURKAT: 2.8;MCF7: 5.1;RT4: 2.5;T-47d: 3.1;U-2 OS: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058960	Uncertain					NA	NA					"HPA058960: AB_2683862"	"unprognostic (2.32e-3)"	"unprognostic (1.17e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.21e-5)"	"unprognostic (8.10e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.03e-2)"	0.5	0.0	0.0	0.1	0.0	0.1	3.6	0.0	0.0	5.4	0.1	0.0	10.3	0.2	0.6	0.2	12.1	0.1	0.6	0.0	0.0	0.0	0.0	19.3	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	5.2	0.0	0.0	1.6	44.6	1.2	29.0	0.1	1.0	0.0	0.3	0.5	0.7	0.0	0.4	0.0	14.7	6.7	5.5	10.3	0.0	0.2	0.0	13.2	1.0	4.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	2.8	0.0	0.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.1	3.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	1.8	6.1	4.6	0.0	0.6	1.5	0.2	0.0	0.0	0.4	0.0	1.0	13.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	6.9	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.6	0.0	0.9	0.0	0.2
CYP4F3	"CYP4F, LTB4H"	ENSG00000186529	"Cytochrome P450 family 4 subfamily F member 3"	Q08477	19	15640897-15662825	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 159.2"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 506.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 30.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	68	"neutrophil: 33.1"	"Lineage enriched"	"Detected in single"	166	"granulocytes: 33.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 20.0;HaCaT: 9.1;Hep G2: 10.9;OE19: 29.3"									HPA058960	Approved					NA	NA					"HPA058960: AB_2683862"	"unprognostic (1.73e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.40e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.07e-1)"	0.4	0.1	0.3	0.3	1.5	24.8	0.1	0.1	2.2	2.1	3.4	6.5	0.0	3.1	0.1	0.4	8.6	0.3	19.8	0.2	0.8	0.2	23.7	159.2	0.7	0.0	0.4	1.9	0.1	0.2	0.0	0.2	0.0	1.6	0.3	0.5	0.0	1.3	0.1	0.1	1.2	13.4	0.1	1.0	2.6	1.7	0.2	1.8	0.0	0.1	1.1	0.8	1.8	2.7	0.0	0.0	33.1	0.1	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	20.0	0.0	0.1	0.0	0.0	9.1	0.0	0.1	0.0	0.3	0.0	0.1	1.9	10.9	0.0	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.1	2.2	0.8	0.2	0.4	1.9	1.6	1.8	8.9	5.9	5.1	2.3	0.9	0.0	0.8	91.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	13.5	23.3	0.2	0.1	0.3	1.7	1.1	506.3	0.0	0.0	50.9	6.2	10.2	0.4	0.0	0.4	0.0	0.0	5.6	0.0	2.5	7.0	0.0	31.2	0.0	0.0	0.2	0.0	0.1	5.6	0.0	0.8	8.3	10.8
CYP4F8		ENSG00000186526	"Cytochrome P450 family 4 subfamily F member 8"	P98187	19	15615218-15630638	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	155	"ductus deferens: 265.6;seminal vesicle: 360.6"	"Cell type enhanced"	"Detected in some"	14	"Glandular cells: 1.7;granulocytes: 1.1;Urothelial cells: 2.4"	"Group enriched"	"Detected in some"	31	"breast cancer: 2.5;prostate cancer: 3.3;urothelial cancer: 10.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"OE19: 2.1;RT4: 1.6;SK-BR-3: 4.4"									HPA058960	Approved					NA	NA					"HPA058960: AB_2683862"	"unprognostic (1.70e-2)"	"unprognostic (5.46e-3)"	"unprognostic (3.21e-2)"	"unprognostic (3.97e-6)"		"unprognostic (3.51e-3)"				"unprognostic (2.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.25e-2)"		"unprognostic (1.15e-2)"			"unprognostic (1.02e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	265.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	360.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.8	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.4
DHRS4	"FLJ11008, humNRDR, SCAD-SRL, SDR-SRL, SDR25C2"	ENSG00000157326	"Dehydrogenase/reductase 4"	Q9BTZ2	14	23953586-23969279	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023972	Uncertain		Approved	"Nuclear membrane,Vesicles"		NA	NA			Vesicles	"Nuclear membrane"	"HPA023972: AB_1854890"	"unprognostic (1.21e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.65e-2)"	"prognostic favorable (4.55e-6)"	"unprognostic (2.03e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.68e-2)"	15.8	18.5	8.3	10.3	13.7	5.9	15.4	4.4	9.6	11.0	22.2	10.2	12.1	30.3	13.7	11.7	17.2	8.3	16.3	16.3	9.0	6.6	65.8	40.3	12.6	13.6	14.0	7.7	12.6	20.6	7.3	9.7	8.9	9.3	17.0	12.4	12.0	17.5	14.4	25.3	16.6	35.2	14.4	9.6	12.4	12.9	13.5	12.6	6.9	17.1	16.1	11.1	10.0	14.8	9.7	22.0	2.6	25.5	7.9	10.6	14.9	7.7	15.7	5.4	8.8	8.6	9.6	0.1	14.6	7.7	5.8	4.6	3.3	8.3	6.6	7.8	7.2	4.0	9.2	4.3	6.0	5.2	17.8	8.9	4.0	13.2	18.3	5.2	5.7	24.6	9.5	7.5	4.8	10.6	6.6	7.2	9.9	5.9	15.8	7.9	26.3	10.4	5.4	5.3	9.0	15.8	16.9	9.5	21.8	6.0	9.0	10.5	8.8	14.0	9.1	6.9	3.6	8.4	7.7	13.4	7.2	7.6	7.4	4.7	12.1	11.2	1.8	6.3	6.5	7.2	2.4	25.5	2.6	8.9	21.0	10.6	9.7	10.1	8.9	22.0	8.3	10.3	9.9	1.1	7.9	11.1	18.5	8.6	14.9	8.3	13.7	4.4	9.6	9.0	6.6	14.0	7.7	9.3	12.6	14.9	26.2	4.7	9.5	11.1	4.7	30.1	7.6	32.1	31.8	14.0	0.0	8.3	66.3	5.2	39.4	10.8	35.9	0.0	8.6	4.2	11.6	9.3	12.8	64.8	26.6	6.4	18.5	16.0	34.4	43.6	10.3	34.4	5.0	3.6	41.8	12.8	6.6	7.0	16.3	63.7	1.6	6.5	11.3	27.0	2.0	11.7	3.2	14.1	63.5	9.0
GGT1	"CD224, D22S672, D22S732, GGT"	ENSG00000100031	"Gamma-glutamyltransferase 1"	P19440	22	24583750-24629005	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Protease, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 54.1;seminal vesicle: 41.7"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 74.5;Alveolar cells type 2: 21.4;Cholangiocytes: 40.8;Ductal cells: 54.8;Enterocytes: 80.7;Hepatocytes: 34.1;Pancreatic endocrine cells: 33.5;Paneth cells: 23.0;Proximal tubular cells: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.6;Karpas-707: 52.5;OE19: 37.9;RPMI-8226: 51.6;RPTEC TERT1: 48.0"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA		4600000	Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (8.13e-3)"	"unprognostic (4.76e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.55e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (4.83e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.10e-2)"	1.6	0.5	1.7	1.7	2.2	2.7	8.2	2.3	2.6	7.3	7.9	1.6	23.7	22.3	1.4	19.9	1.2	0.8	12.2	2.0	1.8	1.2	54.1	29.2	14.3	3.2	1.7	1.6	1.3	17.3	0.0	1.6	1.4	2.2	14.7	2.4	1.4	8.7	41.7	0.9	1.1	20.9	1.7	1.9	4.7	6.6	5.0	2.1	2.4	4.8	1.6	5.5	2.1	1.1	3.3	7.5	15.9	14.6	6.6	8.6	6.6	0.2	19.3	0.2	0.0	0.0	0.1	0.5	0.1	0.6	0.2	0.2	2.6	4.2	0.2	4.3	0.0	3.8	2.8	1.4	0.2	0.1	35.6	2.9	0.1	8.6	14.0	1.5	0.3	11.9	0.4	0.2	0.6	0.4	0.3	0.1	5.3	2.0	52.5	0.2	0.4	0.3	14.6	1.4	37.9	0.2	0.2	2.2	51.6	48.0	0.6	0.2	0.3	0.1	9.3	0.2	5.5	9.3	11.1	2.2	3.5	2.3	10.8	0.3	15.8	5.9	0.2	7.4	15.0	0.1	5.2	14.6	0.4	1.4	6.8	5.2	3.3	7.7	3.4	7.5	0.3	1.0	1.9	15.9	6.6	5.5	0.1	8.6	6.6	1.7	2.2	2.3	2.6	1.8	1.2	1.7	1.6	2.2	2.1	74.5	21.4	3.4	0.1	0.7	0.4	0.4	40.8	2.7	7.9	1.8	0.0	0.9	1.7	54.8	1.1	0.1	80.7	0.0	7.2	0.3	1.3	3.0	5.7	34.1	4.7	0.0	1.2	2.5	3.0	4.1	0.0	2.9	1.7	5.4	2.5	2.0	33.5	23.0	0.4	32.7	0.0	0.0	0.2	0.6	0.7	0.4	0.7	3.2	4.2	0.0
GGT2	GGT	ENSG00000133475	"Gamma-glutamyltransferase 2"	P36268	22	21207973-21227637	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 5.6;salivary gland: 5.5;thyroid gland: 8.4"	"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 7.4;Early spermatids: 3.8;Late spermatids: 14.7"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.4;HeLa: 4.6;Karpas-707: 2.0;U-2197: 13.9"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles		NA	NA			Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (4.27e-1)"	"unprognostic (6.91e-2)"		"unprognostic (7.03e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.38e-5)"	"unprognostic (1.05e-3)"		"unprognostic (5.85e-4)"	"unprognostic (7.97e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.46e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.1	0.2	0.0			1.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.1	2.2	0.0	0.0		0.0	0.1	0.0	0.2	0.0		0.0	0.0		5.5	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.3	1.0			8.4		0.0	0.0	0.0	0.1	0.2	0.4	0.4	0.4	0.5	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	2.4	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.1	0.0	0.0	1.0	0.0	1.5	0.0	0.0	0.1	0.5	0.6	13.9	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.1	0.5	0.0	0.2	0.0	0.1	0.0	0.4	0.4	0.0	0.0	0.5	0.3											3.0	7.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0
GGT5	"GGT-REL, GGTLA1"	ENSG00000099998	"Gamma-glutamyltransferase 5"	P36269	22	24219654-24245142	"Enzymes, Predicted intracellular proteins"	"Glutathione biosynthesis, Leukotriene biosynthesis"	"Acyltransferase, Hydrolase, Protease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Ito cells: 44.2;Sertoli cells: 181.1;Smooth muscle cells: 82.1"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	5	"basophil: 4.0;eosinophil: 7.5;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.5"	"Group enriched"	"Detected in some"	4	"ASC diff: 39.5;ASC TERT1: 30.1;HHSteC: 56.4;HSkMC: 65.0;TIME: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008121, CAB032489"	Uncertain		Approved	"Nucleoli fibrillar center"	"Intracellular and membrane"	NA	NA		18000000	"Nucleoli fibrillar center"		"CAB032489: AB_2111010, HPA008121: AB_1078965"	"unprognostic (8.14e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (6.36e-5)"	"prognostic unfavorable (4.06e-4)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.33e-2)"	20.2	14.8	2.0	5.2	3.5	0.0	13.2	0.5	4.2	10.7	4.0			5.7	7.9	3.6	2.1	10.2	12.1	14.0	2.4	3.4	13.1	13.7	5.1	12.4	4.7		3.9	5.0	2.2	6.0	3.2		6.5	3.4		5.4	6.8	2.5	5.3	7.2	10.1	2.7	4.8	5.6	1.2			17.2		5.2	6.3	9.3	0.1	0.4	7.5	0.9	0.8	0.1	0.4	0.0	0.3	0.0	0.0	39.5	30.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.1	5.2	56.4	0.6	1.4	65.0	0.0	0.7	0.7	0.0	10.6	0.1	0.1	0.1	10.1	0.1	0.0	4.9	0.6	0.1	0.0	0.0	0.9	0.1	1.1	0.0	0.0	1.4	0.0	1.7	0.0	5.6	0.2	0.3	25.2	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.9	1.1	0.0	4.0	0.9	7.5	0.1	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.9	0.8	0.0	0.1	0.0	0.4											3.0	16.5	0.5	3.1	6.3	0.0	4.8	0.0	2.7	11.4	0.0	0.0	0.2	0.0	0.1	0.5	37.5	0.0	0.0	0.2	0.1	8.7	1.3	1.1	0.0	1.6	0.0	0.0	44.2	1.2	2.6	33.6	2.9	3.3	5.4	0.0	0.2	0.3	0.0	22.3	0.0	0.4	181.1	82.1	0.3	0.4	3.9	0.2	0.0	0.0	0.9
GGT6	FLJ90165	ENSG00000167741	"Gamma-glutamyltransferase 6"	Q6P531	17	4556927-4560818	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.4;salivary gland: 52.7"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 136.8;Mucus-secreting cells: 63.3;Paneth cells: 98.2;Undifferentiated cells: 77.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.5"	"Group enriched"	"Detected in some"	8	"RT4: 30.5;SK-BR-3: 10.4;T-47d: 32.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023362, HPA027213"	Approved					NA	NA		33000			"HPA023362: AB_1848955, HPA027213: AB_10601326"	"unprognostic (2.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (9.42e-7)"	"unprognostic (1.56e-1)"	"unprognostic (5.71e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.07e-3)"	0.3	0.4	0.3	12.7	0.3	0.0	3.2	0.3	0.4	4.1	24.9	0.4	1.0	17.0	0.9	15.9	25.2	3.0	7.7	0.3	0.3	0.1	18.8	0.6	4.2	0.3	0.3	0.3	1.5	28.6	0.0	1.0	0.4	0.4	5.7	12.7	0.4	52.7	3.7	0.3	25.2	40.4	2.8	0.3	0.3	8.7	0.8	0.3	1.0	0.7	19.6	18.8	16.5	8.2	0.6	0.7	3.5	0.5	0.6	0.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	30.5	0.1	0.1	0.0	10.4	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.5	0.2	0.4	0.3	0.2	0.3	0.5	0.3	0.1	0.6	0.5	0.4	1.9	0.6	0.5	0.7	0.4	0.0	0.3	0.3	0.3	0.4	0.3	0.1	0.3	0.3	0.4	0.3	32.8	5.8	2.2	16.1	3.7	0.0	0.2	17.8	33.5	29.6	22.7	2.0	0.0	18.3	16.4	0.0	0.0	136.8	0.0	33.4	0.0	0.3	3.4	0.0	0.0	0.1	0.0	5.8	0.0	0.0	0.0	0.6	1.3	0.0	3.6	63.3	0.2	14.4	98.2	0.0	32.1	0.2	0.0	1.0	0.0	0.1	18.2	0.0	0.5	77.9	19.7
GGT7	"D20S101, dJ18C9.2, GGTL3, GGTL5"	ENSG00000131067	"Gamma-glutamyltransferase 7"	Q9UJ14	20	34844720-34872860	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 38.6;Horizontal cells: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013204, HPA013339"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		1500000	Vesicles	Nucleoplasm	"HPA013204: AB_1850347, HPA013339: AB_2668816"	"unprognostic (1.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (1.26e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.61e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.00e-1)"	6.8	6.7	21.6	6.7	23.7	2.9	8.5	42.6	29.1	9.5	11.5	9.7	14.3	9.8	12.3	19.5	6.4	10.5	11.4	13.8	19.7	17.0	9.9	7.2	9.0	10.3	11.2	32.1	13.4	19.5	20.8	18.3	8.5	19.2	11.4	9.6	6.9	18.8	15.3	31.6	11.1	9.0	9.6	11.0	8.3	12.9	5.0	15.6	4.9	16.3	4.3	8.2	9.3	8.5	6.1	2.6	1.5	3.0	3.2	12.8	1.8	2.2	3.3	17.0	17.4	13.4	12.0	15.1	9.4	9.6	7.8	11.6	17.4	11.1	0.0	11.2	7.3	7.9	1.5	7.3	4.1	5.1	0.7	13.1	6.7	5.9	9.1	12.0	0.3	11.1	17.4	4.7	8.7	4.0	23.3	0.6	8.9	5.0	1.2	5.3	3.8	1.7	3.4	3.9	3.8	1.7	0.0	11.6	10.7	11.3	3.3	9.9	11.6	4.8	7.7	12.1	6.7	5.9	6.1	0.2	26.8	10.7	2.5	5.3	13.1	1.7	0.8	31.5	0.6	9.8	1.5	3.0	1.4	7.4	2.0	2.1	5.6	6.3	2.8	2.6	6.1	12.8	8.9	0.3	3.2	0.7	1.4	4.8	1.8	21.6	23.7	42.6	29.1	19.7	17.0	11.2	32.1	19.2	15.6	3.0	2.4	0.9	17.1	6.5	38.6	1.6	22.9	1.4	3.4	17.4	11.8	18.6	0.0	13.9	2.1	2.1	10.5	0.0	4.9	9.8	11.9	9.2	2.3	10.2	4.0	38.1	10.4	0.6	1.9	0.5	11.5	2.4	10.1	3.6	16.0	9.4	6.7	14.0	7.4	5.1	16.9	6.5	8.6	11.1	10.6	3.8	14.1	4.1	17.8	12.0
GGTLC1	"dJ831C21.1, dJ831C21.2, GGTLA3, GGTLA4"	ENSG00000149435	"Gamma-glutamyltransferase light chain 1"	Q9BX51	20	23985050-23988779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	13	"lung: 24.2;testis: 11.1"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 128.1;Early spermatids: 37.6;Late spermatids: 92.1"	"Cancer enriched"	"Detected in some"	8	"lung cancer: 7.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.3;SK-BR-3: 1.7;T-47d: 1.2;U-2197: 4.5"									"HPA045635, HPA047534"	Uncertain					NA	NA					"HPA045635: AB_2679400, HPA047534: AB_2680079"				"unprognostic (3.14e-1)"			"unprognostic (1.62e-1)"	"unprognostic (1.94e-2)"			"unprognostic (5.32e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1			1.4		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.8	0.1	0.0	0.0	1.7	0.0	0.0	1.2	0.0	0.0	0.0	0.1	4.5	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2											128.1	14.9	0.0	0.0	0.0	0.0	0.0	5.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	37.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	7.9	0.4	0.0	0.0	0.0	0.0	0.0
GGTLC2	GGTL4	ENSG00000100121	"Gamma-glutamyltransferase light chain 2"	Q14390	22	22644475-22647903	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"testis: 11.1"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 20.8;Early spermatids: 22.5;Late spermatids: 5.2;Spermatocytes: 10.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.6;RPMI-8226: 4.6;THP-1: 2.8;U-2 OS: 2.4"									"HPA045635, HPA047534"	Uncertain					NA	NA					"HPA045635: AB_2679400, HPA047534: AB_2680079"				"unprognostic (2.58e-2)"			"unprognostic (2.35e-2)"	"unprognostic (7.17e-2)"		"unprognostic (2.96e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.48e-2)"		"unprognostic (1.55e-1)"		0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0			0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	11.1			0.2		0.0	0.0	0.0	0.3	0.9	1.4	1.3	0.8	0.7	0.6	0.0	0.5	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	4.6	1.0	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.3	2.8	0.0	0.0	2.4	0.0	0.0	0.7	0.5	0.1	0.0	0.2	0.0	0.5	1.3	0.0	0.0	0.5	0.2	0.3	0.7	0.4	0.9	0.0	0.0	0.3	1.4	0.8	0.7	0.0	0.7	0.6											20.8	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	5.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	10.9	0.1	0.0	0.0	0.0	0.0	0.0
GSTK1	GST13	ENSG00000197448	"Glutathione S-transferase kappa 1"	Q9Y2Q3	7	143244093-143270854	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 923.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA006311, HPA022904"	Supported		Supported	Peroxisomes		NA	NA		1300000	Peroxisomes		"HPA006311: AB_1849786, HPA022904: AB_1849787"	"prognostic favorable (4.41e-6)"	"unprognostic (2.40e-1)"	"unprognostic (6.53e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.99e-2)"	"unprognostic (7.27e-2)"	"prognostic favorable (2.10e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.13e-2)"	"unprognostic (2.15e-2)"	38.0	45.3	14.0	45.3	19.9	29.0	43.0	5.6	19.6	30.4	69.0	19.9	35.7	58.0	24.8	39.8	37.8	27.4	55.2	56.4	15.0	13.1	67.6	97.1	35.4	52.2	24.3	16.3	22.7	39.9	46.2	20.7	41.5	23.9	28.0	43.5	34.4	72.9	35.8	38.9	30.0	91.0	22.2	17.5	58.5	34.8	18.9	20.8	27.1	48.0	56.6	50.3	29.4	26.6	32.8	57.1	35.7	75.4	22.3	99.0	95.2	27.3	19.7	2.8	24.6	43.6	62.7	13.1	16.2	27.8	14.5	29.0	11.9	70.3	15.6	23.1	23.4	21.9	41.6	10.8	25.3	12.7	30.0	11.7	12.7	14.8	18.6	30.1	15.3	20.8	56.5	31.2	16.7	11.9	21.7	38.5	20.5	17.8	19.1	38.8	21.1	15.6	27.8	6.5	53.4	29.9	13.5	0.4	30.8	50.2	15.1	11.4	15.6	29.7	48.4	24.6	17.7	23.3	21.5	22.7	7.9	7.3	20.6	13.7	32.7	15.3	3.5	28.6	61.8	16.2	35.7	67.9	25.8	41.1	74.8	39.6	32.8	76.4	52.4	57.1	21.9	39.5	38.1	21.2	22.3	75.4	23.9	99.0	95.2	14.0	19.9	5.6	19.6	15.0	13.1	24.3	16.3	23.9	20.8	65.5	100.3	104.0	135.2	101.4	10.8	146.0	216.6	120.5	84.2	115.1	11.8	257.6	247.1	119.7	471.4	96.3	424.2	23.3	105.8	108.4	95.9	76.6	140.9	263.3	268.7	7.9	147.4	136.2	267.9	923.0	67.3	177.0	143.4	164.1	202.4	80.8	97.6	394.4	47.7	486.1	13.7	84.1	117.9	6.2	8.8	101.8	153.7	238.2	288.1	173.8
GSTZ1	"GSTZ1-1, MAAI, MAI"	ENSG00000100577	"Glutathione S-transferase zeta 1"	O43708	14	77320884-77331597	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Isomerase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 90.4"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 348.1;Late spermatids: 326.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004701	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		62000	Cytosol	Nucleoplasm	"HPA004701: AB_1078990"	"prognostic favorable (4.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (7.90e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.92e-2)"	4.6	12.9	5.6	5.9	6.8	2.8	8.5	2.1	9.0	5.0	8.1	10.8	7.5	8.1	4.1	9.5	9.0	5.5	8.0	5.5	5.4	5.0	8.9	90.4	4.4	10.7	6.9	6.9	2.8	7.1	9.3	5.1	11.0	5.8	8.0	8.0	9.5	22.5	4.7	14.8	7.4	7.2	3.8	7.9	5.0	5.9	18.2	5.2	8.6	8.3	14.3	8.9	4.9	4.5	8.2	15.3	7.2	16.0	3.4	5.6	5.0	6.5	12.5	9.9	7.0	6.3	8.7	16.8	4.1	4.2	7.7	10.9	4.2	16.5	14.6	5.9	4.8	4.8	8.4	6.7	7.9	7.4	7.7	6.7	7.1	4.8	8.9	9.9	2.6	5.9	8.1	8.6	4.4	7.5	4.3	6.6	8.7	5.9	13.5	5.1	60.8	4.0	5.5	2.9	22.6	10.0	7.0	10.4	11.3	11.7	8.0	10.9	9.9	9.1	18.2	12.9	5.8	29.7	3.9	4.5	6.0	20.4	6.8	3.0	10.1	10.8	12.8	15.6	4.0	7.5	6.6	11.1	7.2	1.9	16.0	1.9	6.4	3.4	2.8	15.3	8.2	2.9	2.4	1.1	3.4	13.5	10.4	5.6	5.0	5.6	6.8	2.1	9.0	5.4	5.0	6.9	6.9	5.8	5.2	6.0	8.1	12.7	18.0	11.8	6.8	12.0	50.9	10.7	5.7	8.7	3.9	76.5	39.7	34.9	105.1	8.7	47.2	23.3	59.7	57.9	10.6	19.8	3.5	348.1	39.6	15.9	27.6	9.8	28.3	326.5	10.9	14.4	16.9	35.1	36.9	20.9	39.0	38.6	5.6	58.4	11.2	0.0	10.3	33.5	24.7	12.3	63.7	7.7	45.9	17.7
HPGD	SDR36C1	ENSG00000164120	"15-hydroxyprostaglandin dehydrogenase"	P15428	4	174490177-174523154	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 193.3"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 273.6;Extravillous trophoblasts: 488.8;granulocytes: 816.1;Urothelial cells: 266.0"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 52.4"	"Region enriched"	"Detected in single"	4	"pons and medulla: 3.8"	"Group enriched"	"Detected in many"	5	"basophil: 37.7;T-reg: 15.1"	"Group enriched"	"Detected in many"	71	"granulocytes: 37.7;T-cells: 15.1"	"Cell line enhanced"	"Detected in some"		"A549: 27.7;ASC diff: 17.2;HEL: 60.6;RT4: 94.3;SuSa: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004919, HPA005679"	Enhanced		Supported	Nucleoplasm,Cytosol		No	NA			Cytosol	Nucleoplasm	"HPA004919: AB_1079081, HPA005679: AB_1079080"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (3.20e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-4)"	"unprognostic (2.33e-2)"	5.1	2.6	0.5	7.9	0.6	0.0	24.6	0.4	0.6	23.0	73.3	0.5	2.5	22.9	13.4	7.5	32.0	4.5	10.7	1.2	0.6	0.7	8.5	63.7	22.9	7.9	0.8	0.5	2.3	0.4	0.0	0.9	193.3	3.8	20.1	8.4	4.6	3.0	1.1	1.6	15.3	64.5	9.3	0.5	2.9	36.3	1.9	0.5	5.5	0.4	5.0	7.9	61.2	31.8	0.1	0.2	37.7	0.1	0.3	15.1	1.0	0.0	27.7	0.0	0.0	17.2	1.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	2.5	2.5	0.0	0.0	0.0	0.5	60.6	2.1	0.0	0.0	0.3	0.1	0.9	0.4	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	15.8	1.4	2.8	0.0	0.2	5.7	94.3	0.1	0.1	0.0	0.2	0.6	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	37.7	0.1	5.4	3.7	0.0	5.7	0.1	1.9	1.6	0.2	0.0	0.6	1.5	0.4	0.3	0.0	0.0	15.1	1.0	0.5	0.6	0.4	0.6	0.6	0.7	0.8	0.5	3.8	0.5	14.9	46.1	5.2	57.7	15.3	3.1	0.4	43.3	5.3	20.5	21.0	0.0	25.6	18.3	2.4	1.1	0.5	273.6	0.0	86.5	488.8	12.1	51.1	816.1	165.7	20.7	0.0	8.1	18.4	16.1	0.2	18.4	10.6	72.6	1.0	48.2	0.0	26.0	217.5	0.0	68.8	0.6	0.0	6.6	0.4	0.4	19.6	47.4	50.3	31.0	266.0
HPGDS	"GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS"	ENSG00000163106	"Hematopoietic prostaglandin D synthase"	O60760	4	94298535-94342876	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 24.8"	"Group enriched"	"Detected in many"	10	"granulocytes: 1000.1;Hofbauer cells: 476.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"basophil: 15.8"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 15.8"	"Group enriched"	"Detected in some"	8	"HEL: 32.4;HMC-1: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA024035	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		170000	"Vesicles, Cytosol"	Nucleoplasm	"HPA024035: AB_1855743"	"unprognostic (5.71e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.01e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.75e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	14.3	2.9	8.0	1.6	12.1	1.6	5.8	2.0	7.7	5.4	6.9	4.4	0.2	7.5	4.7	3.3	4.1	2.5	9.3	3.0	8.4	3.6	2.5	1.3	12.7	0.9	9.6	2.4	1.5	1.8	1.7	1.5	24.8	9.0	6.4	7.5	2.9	3.8	2.2	1.4	5.8	8.6	5.8	14.6	1.4	4.4	1.8	12.1	1.5	1.2	2.8	1.5	4.5	3.5	0.0	0.1	15.8	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	2.5	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	8.0	12.1	2.0	7.7	8.4	3.6	9.6	2.4	9.0	12.1	11.9	75.3	0.0	0.8	3.7	0.0	0.0	0.0	2.7	6.8	0.0	0.0	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.5	4.1	4.0	1000.1	0.0	476.4	0.0	6.8	0.0	3.9	0.0	0.3	14.5	3.3	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.1	4.6	4.6	0.0	0.0	0.1
HSD17B10	"17b-HSD10, ABAD, CAMR, ERAB, HADH2, MHBD, MRPP2, MRXS10, SDR5C1"	ENSG00000072506	"Hydroxysteroid 17-beta dehydrogenase 10"	Q99714	X	53431258-53434373	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase	"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 343.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001432	Approved					NA	NA		1800000			"HPA001432: AB_1078740"	"unprognostic (1.27e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.64e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.92e-1)"	"unprognostic (9.51e-2)"	20.9	29.8	13.2	19.1	14.5	16.4	15.9	7.9	14.0	16.9	20.6	16.2	20.2	17.2	17.1	19.0	31.3	14.8	19.6	42.6	11.9	14.0	33.9	96.7	12.7	21.6	16.1	9.7	21.0	32.7	12.5	18.4	25.0	14.9	15.3	19.4	13.0	23.2	17.8	35.4	22.9	17.4	18.6	14.8	19.7	17.4	8.6	14.0	25.6	28.4	39.0	26.0	16.1	17.9	30.4	53.2	12.8	38.2	27.7	33.3	32.9	22.3	38.3	18.7	34.7	18.4	8.1	28.3	13.9	13.9	37.1	24.4	39.3	19.3	38.2	12.7	15.9	24.1	23.5	60.2	28.1	20.4	30.2	33.8	18.0	54.9	32.5	30.9	33.9	28.2	17.3	26.7	28.7	16.1	8.1	27.1	34.4	25.7	30.3	17.2	78.9	30.0	51.0	51.8	30.3	49.5	30.7	34.6	67.6	28.5	24.8	33.1	43.6	40.0	47.9	25.3	24.9	50.4	31.6	12.1	15.9	25.3	33.1	21.0	24.8	34.5	47.2	22.1	71.4	23.4	12.8	38.2	11.4	27.0	36.7	27.8	30.0	25.1	26.7	53.2	30.4	21.1	22.2	3.2	27.7	26.8	29.0	33.3	32.9	13.2	14.5	7.9	14.0	11.9	14.0	16.1	9.7	14.9	14.0	44.7	34.1	58.8	68.9	76.7	11.0	53.6	96.8	29.4	30.7	96.0	3.9	152.6	240.4	110.3	1.3	54.5	72.5	116.8	117.5	226.1	88.0	68.7	56.4	343.1	121.0	12.7	100.4	52.8	71.2	4.5	72.5	86.0	91.1	131.7	59.9	45.2	90.4	42.1	89.1	333.9	11.4	77.6	85.6	15.1	62.3	101.6	126.8	78.8	78.6	62.3
LTC4S	MGC33147	ENSG00000213316	"Leukotriene C4 synthase"	Q16873	5	179793980-179796647	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid biosynthesis, Lipid metabolism"	"Lyase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 31.3"	"Cell type enriched"	"Detected in many"	6	"granulocytes: 332.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 8.5;eosinophil: 31.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 31.3"	"Cell line enriched"	"Detected in some"	10	"HMC-1: 52.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA044688			Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			Nucleoplasm	"Endoplasmic reticulum, Cytosol"	"HPA044688: "	"unprognostic (8.94e-2)"	"unprognostic (2.40e-2)"			"unprognostic (9.35e-3)"		"unprognostic (3.57e-2)"	"unprognostic (1.24e-2)"		"unprognostic (9.40e-2)"	"unprognostic (4.53e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.62e-1)"	9.0	6.7	3.5	2.8	3.5	8.6	4.6	1.7	5.0	6.9	5.0	9.4	5.4	3.6	8.7	10.4	4.2	13.0	15.7	11.3	3.9	3.1	6.2	2.3	28.3	8.0	6.8	4.2	5.8	2.4	2.0	3.2	2.9	4.3	5.6	1.9	3.3	7.4	11.6	2.7	3.5	5.7	4.5	6.3	6.7	5.0	3.3	3.9	0.8	5.3	5.6	3.2	3.6	3.9	0.1	4.5	31.3	0.3	2.2	1.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	5.3	0.0	0.2	0.2	0.3	52.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	8.5	0.2	31.3	0.5	0.3	1.7	0.1	1.2	0.8	4.5	0.1	0.2	0.5	0.1	2.2	0.0	0.2	0.1	0.3	3.5	3.5	1.7	5.0	3.9	3.1	6.8	4.2	4.3	3.9	0.0	5.6	2.2	7.5	8.9	0.2	0.0	12.7	4.0	3.4	14.0	0.0	6.9	1.7	4.1	0.3	11.3	0.4	0.0	2.1	1.5	4.7	3.1	332.3	0.8	33.8	0.0	2.9	53.4	8.9	0.0	15.3	23.5	1.7	1.0	1.6	0.0	2.1	0.0	44.6	40.2	0.3	0.0	0.9	0.0	0.7	6.0	2.5	5.0	2.6	5.0
MGST1	"GST12, MGST-I"	ENSG00000008394	"Microsomal glutathione S-transferase 1"	P10620	12	16347142-16609259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 382.8"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 3471.1;Proximal tubular cells: 978.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 46.1;myeloid DC: 34.1"	"Group enriched"	"Detected in many"	15	"dendritic cells: 34.1;monocytes: 46.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 342.0;ASC TERT1: 132.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044840	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA			Mitochondria	"Endoplasmic reticulum"	"HPA044840: AB_10965550"	"unprognostic (4.57e-2)"	"unprognostic (4.80e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.92e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (9.90e-2)"	"unprognostic (4.61e-1)"	"prognostic favorable (1.97e-4)"	"unprognostic (4.19e-1)"	127.9	106.0	18.5	10.8	32.6	9.5	116.8	10.3	14.0	9.3	39.7	9.6	2.6	17.0	4.1	6.4	19.5	6.9	26.6	12.1	19.6	13.9	56.9	382.8	42.0	2.7	18.9	8.9	3.1	12.4	0.8	5.3	8.7	18.4	23.5	28.3	3.0	14.7	8.2	8.9	7.0	15.5	11.5	20.1	0.9	10.3	6.8	12.0	0.0	69.9	13.9	3.6	32.6	37.2	0.2	34.1	2.7	46.1	0.0	0.2	13.0	0.0	30.6	7.3	8.5	342.0	132.0	0.0	25.1	25.7	13.7	21.3	11.6	51.3	0.0	3.0	32.1	43.1	0.1	19.0	40.2	12.4	0.0	2.5	10.4	17.0	40.7	79.9	20.2	0.0	85.6	44.8	41.8	44.1	34.0	24.0	0.0	7.3	0.0	29.4	6.2	0.0	8.1	60.9	0.0	24.3	0.0	4.3	13.8	30.8	60.5	1.3	1.1	39.2	25.2	1.0	41.3	27.1	11.4	15.1	14.1	1.9	27.7	32.3	0.0	0.0	0.0	46.4	32.3	0.4	2.7	46.1	0.4	0.0	7.0	0.1	0.2	0.0	0.0	34.1	0.0	0.0	0.0	1.5	0.0	1.5	9.6	0.2	13.0	18.5	32.6	10.3	14.0	19.6	13.9	18.9	8.9	18.4	12.0	247.1	493.0	46.4	120.5	22.8	0.0	5.3	738.8	293.1	502.7	68.0	0.0	2.3	154.2	22.7	20.8	14.2	262.1	46.7	371.4	189.8	162.1	379.2	32.4	3471.1	168.6	0.0	43.8	78.5	223.7	10.9	30.8	51.0	37.1	187.6	224.9	0.0	374.3	135.3	106.4	978.0	1.0	0.0	12.2	0.5	2.2	15.4	6.6	37.4	362.2	564.6
MGST2	MGST-II	ENSG00000085871	"Microsomal glutathione S-transferase 2"	Q99735	4	139665768-139740745	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid metabolism"	"Lyase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 46.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 46.9;monocytes: 25.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 47.4;OE19: 91.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA010707	Approved					NA	NA					"HPA010707: AB_1853922"	"unprognostic (9.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.33e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.78e-2)"	"unprognostic (6.41e-2)"	"prognostic favorable (3.22e-9)"	"unprognostic (4.10e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.01e-2)"	26.9	30.2	6.9	9.7	10.8	7.4	29.0	12.6	9.3	16.4	27.3	7.3	31.3	27.3	12.2	19.4	54.9	14.7	42.0	26.9	7.4	9.0	25.3	79.1	20.6	21.6	10.1	5.9	10.6	27.8	16.4	18.2	19.2	10.2	23.3	25.4	14.7	30.4	36.7	20.4	24.2	60.3	13.3	10.7	19.6	15.2	29.0	8.8	8.3	23.7	40.9	26.8	19.1	22.6	0.5	46.9	8.1	25.9	5.8	8.8	8.8	6.6	9.7	5.0	0.0	0.8	2.7	3.0	1.2	11.0	0.5	1.8	10.1	47.4	0.0	27.7	2.9	2.4	12.6	8.9	13.7	0.8	3.7	8.0	29.3	10.7	40.0	2.3	25.2	22.6	9.2	33.7	0.3	2.1	11.1	27.7	0.0	12.1	4.4	4.0	5.5	0.0	4.1	1.1	91.7	9.9	2.1	5.9	8.9	25.8	14.3	12.7	3.8	9.0	14.1	10.7	0.3	9.0	33.5	17.6	0.9	4.8	1.3	1.0	5.2	3.6	1.6	0.6	42.7	2.2	8.1	25.9	7.0	1.1	15.4	0.7	0.3	1.9	0.9	35.7	0.5	0.6	0.6	4.4	5.8	4.8	46.9	8.8	8.8	6.9	10.8	12.6	9.3	7.4	9.0	10.1	5.9	10.2	8.8	23.8	29.3	18.2	223.2	54.3	8.1	90.8	229.3	57.6	47.8	90.7	23.6	70.4	76.3	102.7	5.6	212.7	268.6	23.3	122.5	52.4	30.4	143.0	43.7	322.9	310.1	6.4	117.0	164.5	94.6	9.0	41.1	102.8	37.1	19.0	165.9	13.7	108.9	204.6	31.5	203.6	2.7	12.9	48.4	3.7	15.1	109.2	56.2	27.1	227.8	357.7
MGST3	GST-III	ENSG00000143198	"Microsomal glutathione S-transferase 3"	O14880	1	165630861-165661796	"Enzymes, Predicted membrane proteins"		"Lyase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 1846.4;Syncytiotrophoblasts: 1983.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 88.9;HDLM-2: 94.3;OE19: 97.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053311, HPA077929"	Enhanced		Approved	Nucleoplasm		NA	NA		40000	Nucleoplasm		"HPA053311: AB_2682108, HPA077929: "	"unprognostic (1.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.78e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	42.8	30.8	52.5	9.7	30.5	19.0	51.2	17.9	56.0	18.4	39.7	18.4	19.1	65.2	19.5	101.8	19.7	20.6	26.5	133.6	38.1	33.9	45.2	29.5	20.8	11.0	44.2	37.6	22.7	17.7	11.1	18.3	30.9	39.6	21.2	40.4	20.3	29.8	20.6	87.2	15.6	53.4	24.7	38.7	12.4	29.8	19.4	23.3	2.7	25.7	41.8	8.2	19.9	17.3	21.3	35.1	20.7	47.0	15.7	38.0	40.7	22.2	16.3	17.7	13.9	62.1	37.3	88.9	18.6	30.0	14.5	25.3	17.0	29.0	1.4	14.7	22.7	14.3	27.2	4.3	18.2	14.7	94.3	11.1	3.4	12.8	7.7	17.5	5.3	7.5	31.8	14.7	20.0	7.7	28.6	23.6	6.1	8.3	8.5	27.1	4.9	5.9	12.3	38.7	97.4	21.0	5.6	7.6	2.8	76.5	20.9	13.7	16.8	18.7	24.3	37.0	37.1	18.5	26.2	21.4	18.0	10.7	12.4	13.4	6.3	4.3	0.7	33.4	14.1	11.6	10.4	45.7	20.7	30.1	37.0	30.3	21.3	38.0	33.5	35.1	19.9	24.4	26.7	9.8	15.7	47.0	15.1	32.3	40.7	52.5	30.5	17.9	56.0	38.1	33.9	44.2	37.6	39.6	23.3	95.3	125.6	83.1	202.5	202.9	129.1	591.8	331.2	242.2	134.2	528.7	251.3	1846.4	848.8	339.3	13.2	253.1	716.8	630.8	371.6	1154.8	298.4	174.8	89.0	248.3	760.5	123.9	146.8	184.8	114.8	21.3	359.3	238.2	492.6	405.8	197.9	162.7	335.4	599.7	375.8	841.2	122.6	498.0	374.9	15.6	33.3	203.4	1983.2	87.4	339.8	197.4
PLPP3	"LPP3, PAP-2b, PPAP2B"	ENSG00000162407	"Phospholipid phosphatase 3"	O14495	1	56494747-56645301	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Ito cells: 854.4;Leydig cells: 1011.7;Peritubular cells: 374.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 168.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 5.4;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	7	"B-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 105.3;ASC TERT1: 52.6;HSkMC: 65.0;U-2197: 95.5"									"HPA028892, HPA072751"	Uncertain		Supported	"Golgi apparatus"		NA	Yes			"Golgi apparatus"		"HPA028892: AB_10602149, HPA072751: AB_2686555"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.09e-1)"	46.4	17.2	29.0	10.8	30.7	4.2	39.1	13.5	27.5	102.7	15.5	33.8	22.1	8.1	32.7	36.9	20.8	36.7	24.0	23.3	39.9	13.5	30.2	57.7	24.3	6.7	19.2	30.1	27.9	12.2	30.7	7.2	70.9	20.0	37.7	14.4	34.7	22.4	58.7	16.6	24.4	12.5	32.9	16.5	7.9	18.7	23.4	29.7	5.2	107.1	19.4	6.7	35.8	44.0	5.4	0.0	0.8	0.3	0.0	0.0	0.2	0.4	1.5	2.0	0.2	105.3	52.6	5.0	5.5	5.6	5.1	2.5	4.4	0.8	0.7	0.6	8.3	5.7	0.8	0.3	0.1	1.0	0.0	1.3	0.1	0.6	6.1	2.5	0.0	0.0	65.0	0.4	4.9	4.1	3.6	4.8	0.0	0.4	0.0	5.5	0.4	0.0	0.0	6.2	1.2	6.1	0.0	0.0	0.2	0.8	4.6	0.0	4.1	1.7	2.3	0.5	6.4	0.7	0.0	3.0	25.8	2.1	95.5	0.2	0.0	0.0	0.0	4.5	0.2	1.8	0.0	0.3	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	4.5	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.2	29.0	30.7	13.5	27.5	39.9	13.5	19.2	30.1	20.0	29.7	23.8	20.5	11.5	20.0	0.0	3.2	0.0	56.0	8.1	23.9	21.0	0.0	102.0	18.3	16.0	5.7	50.7	10.7	23.3	7.9	10.3	54.5	13.7	3.5	84.4	36.2	0.0	2.4	854.4	45.1	12.0	1011.7	10.2	0.0	1.0	10.3	146.0	8.7	7.0	374.8	18.2	2.5	135.8	0.0	4.3	2.5	0.0	179.8	4.3	7.8	16.5
PTGDS	"L-PGDS, PGDS"	ENSG00000107317	"Prostaglandin D2 synthase"	P41222	9	136975092-136981742	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Mast cell degranulation, Prostaglandin biosynthesis, Prostaglandin metabolism, Transport"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 286.6;retina: 331.2"	"Group enriched"	"Detected in many"	11	"Leydig cells: 35232.9;Peritubular cells: 61248.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	27	"plasmacytoid DC: 140.9"	"Lineage enriched"	"Detected in many"	27	"dendritic cells: 140.9"	"Group enriched"	"Detected in some"	6	"HHSteC: 106.3;HSkMC: 51.8"									"HPA004938, CAB009916"	Approved				"Secreted to blood"	NA	NA		4300000000			"CAB009916: AB_2174617, HPA004938: AB_1855745"	"unprognostic (2.79e-2)"	"unprognostic (3.96e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.19e-7)"	"unprognostic (8.49e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.21e-2)"	34.1	27.9	138.1	37.5	159.8	2.5	11.3	61.5	154.6	260.4	10.5	192.5	23.0	6.4	22.5	130.0	26.0	72.4	65.8	286.6	121.0	85.2	22.3	6.0	39.7	114.8	170.8	130.6	7.0	20.0	1.8	20.6	38.5	118.8	78.5	4.2	331.2	18.8	149.8	17.0	19.7	11.2	18.6	188.0	50.1	13.5	218.5	103.2	3.3	3.4	4.3	51.1	49.5	75.8	0.0	140.9	0.2	0.1	0.3	5.2	1.0	0.0	0.0	0.0	0.0	1.0	3.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	4.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	106.3	0.0	0.2	51.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.2	0.1	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.1	13.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	5.2	0.1	0.3	0.0	0.4	0.6	0.1	0.0	0.1	1.1	0.2	0.3	0.0	140.9	0.1	1.0	138.1	159.8	61.5	154.6	121.0	85.2	170.8	130.6	118.8	103.2	0.0	1.1	0.0	3.5	62.5	41.8	283.2	0.0	0.0	0.0	130.9	49.1	12.3	58.0	0.3	163.9	98.7	0.0	0.0	0.0	31.2	935.4	19.2	1.1	1.6	48.0	20.6	0.0	51.5	2.8	458.6	35232.9	41.1	199.1	1.8	0.0	4317.3	1.2	0.0	61248.9	0.6	110.6	161.7	44.3	116.5	105.1	70.0	29.6	37.4	0.0	14.4
PTGES	"MGST-IV, MGST1-L1, MGST1L1, PIG12, TP53I12"	ENSG00000148344	"Prostaglandin E synthase"	O14684	9	129738331-129753047	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 59.8;placenta: 51.7;seminal vesicle: 182.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 118.4;Extravillous trophoblasts: 226.1;Fibroblasts: 92.9;Syncytiotrophoblasts: 231.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 16.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 30.0;BEWO: 31.9;GAMG: 57.8;HaCaT: 41.7;SK-BR-3: 30.6;U-2197: 79.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA045064	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA045064: AB_10795889"	"unprognostic (2.92e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (2.22e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.20e-2)"	17.0	0.6	1.1	6.2	1.7	3.0	16.7	1.1	1.8	11.9	4.2	0.8	59.8	1.2	2.0	9.1	8.7	2.7	4.1	4.2	2.1	3.5	3.9	0.4	3.5	3.1	1.3	0.7	2.7	0.6	6.3	0.7	51.7	2.1	11.2	2.0	2.9	16.3	182.9	2.5	19.8	3.7	4.8	1.4	1.3	3.4	9.9	0.6	2.3	1.7	6.6	14.1	14.5	15.0	0.0	0.1	16.8	3.2	0.0	0.0	0.1	0.2	18.7	0.0	8.9	30.0	10.4	31.9	1.4	12.3	0.2	0.3	0.9	13.7	0.0	0.5	3.4	57.8	41.7	0.1	1.4	0.1	0.0	0.1	0.0	13.3	0.0	0.7	0.0	0.0	6.1	9.7	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	8.9	1.6	0.0	0.0	0.0	1.0	19.9	0.1	0.7	16.7	30.6	0.1	1.3	16.0	0.0	0.0	0.0	0.0	79.1	0.0	0.0	0.0	0.0	15.7	0.0	0.1	16.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	3.2	0.0	0.0	0.1	1.1	1.7	1.1	1.8	2.1	3.5	1.3	0.7	2.1	0.6	0.0	0.0	0.0	8.2	15.9	0.0	0.0	0.0	0.0	4.5	3.5	0.0	118.4	1.7	10.6	0.4	0.3	0.0	0.0	1.0	226.1	92.9	6.9	1.1	0.0	15.4	0.0	7.0	0.0	0.0	0.0	0.3	3.8	13.5	12.6	6.4	0.0	5.7	0.0	0.0	0.5	0.0	0.0	11.2	0.3	0.0	37.6	231.0	0.0	0.3	38.2
PTGES2	"C9orf15, FLJ14038"	ENSG00000148334	"Prostaglandin E synthase 2"	Q9H7Z7	9	128120693-128128462	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.5"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 606.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020631, HPA020733"	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA020631: AB_1855887, HPA020733: AB_2670508"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.33e-2)"	"prognostic favorable (5.83e-7)"	"unprognostic (2.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"	9.3	17.0	16.5	9.2	17.8	4.4	7.4	15.3	24.1	7.1	14.8	9.9	7.6	17.7	8.1	9.0	12.6	8.4	10.0	36.4	17.4	14.0	13.2	13.0	5.8	10.2	14.2	11.6	9.2	18.3	11.7	14.3	10.7	10.5	8.0	7.0	13.2	16.2	12.0	73.5	9.3	13.2	5.9	7.0	9.5	14.3	5.8	9.8	9.3	10.5	16.2	13.3	8.5	7.3	5.2	8.2	1.2	6.3	3.7	6.5	2.9	12.7	35.8	4.0	14.8	3.6	3.7	12.2	9.8	5.5	12.4	6.6	26.7	20.0	11.3	15.7	3.9	9.7	33.2	5.8	12.1	1.7	8.1	15.6	5.8	27.1	24.9	11.1	11.7	11.6	5.0	8.8	10.0	6.9	3.8	8.5	12.0	12.8	7.0	4.1	39.5	14.0	22.4	12.8	15.4	29.0	10.6	7.9	28.8	8.4	9.6	20.0	12.0	14.2	22.6	9.5	2.0	20.2	6.3	11.1	12.8	15.8	17.2	17.8	16.2	7.9	11.0	9.7	9.1	11.8	1.2	6.0	1.0	5.6	6.3	6.5	5.2	3.7	5.9	6.7	4.5	4.3	5.1	1.1	3.7	2.8	8.2	4.2	2.9	16.5	17.8	15.3	24.1	17.4	14.0	14.2	11.6	10.5	9.8	14.9	5.4	25.3	29.8	20.4	34.7	606.9	35.7	0.0	6.8	22.7	19.6	69.1	124.3	64.1	1.9	21.1	88.3	0.0	44.8	49.4	20.3	34.0	14.9	33.3	50.6	35.0	43.4	15.4	22.9	3.2	28.4	33.8	54.0	154.1	52.3	18.2	52.2	51.8	20.5	79.0	38.1	19.4	28.3	2.3	56.6	21.5	55.7	21.7	83.1	40.8
PTGES3	"cPGES, p23, TEBP"	ENSG00000110958	"Prostaglandin E synthase 3"	Q15185	12	56663341-56688408	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 358.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034319, HPA038672, HPA038673"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		580000	Cytosol	Nucleoplasm	"CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.60e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (4.44e-6)"	"unprognostic (4.33e-3)"	"unprognostic (3.64e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.07e-1)"	44.7	41.4	56.0	41.2	55.7	39.6	175.0	44.2	51.7	49.0	51.9	38.1	49.5	46.4	57.7	52.0	52.6	69.8	36.0	46.0	54.6	57.2	52.1	67.1	46.4	62.0	67.0	41.4	82.3	55.1	43.2	49.2	50.3	57.0	60.7	55.3	24.0	36.6	49.4	64.2	37.0	46.7	64.7	72.5	42.7	36.6	39.7	65.1	53.5	72.5	36.7	55.1	72.7	358.9	40.6	36.9	27.3	74.8	29.2	42.5	60.5	81.4	71.0	57.7	34.3	42.5	38.6	87.9	53.4	40.8	68.8	51.4	60.1	85.9	90.3	81.1	45.5	46.3	52.5	108.0	69.7	87.2	66.3	71.9	70.5	44.9	69.5	31.1	83.7	51.2	27.9	51.0	51.9	63.1	65.5	70.7	58.1	113.0	86.5	67.1	50.8	83.1	79.6	98.5	71.9	83.0	72.7	54.4	121.2	60.5	63.8	74.8	43.7	54.5	78.6	46.2	79.6	90.5	70.3	42.3	41.3	48.1	49.5	73.7	36.5	100.4	72.6	45.0	69.1	74.3	27.3	37.5	23.2	32.0	59.0	42.0	40.6	42.5	38.1	36.9	28.5	42.3	36.4	14.8	29.2	74.8	31.3	42.5	60.5	56.0	55.7	44.2	51.7	54.6	57.2	67.0	41.4	57.0	65.1	166.7	121.6	178.4	623.1	343.3	128.5	151.7	150.3	313.2	146.7	179.7	72.6	370.5	316.7	252.0	38.5	189.7	176.9	116.8	186.9	545.4	268.2	456.4	232.8	165.2	311.0	106.5	250.8	168.1	180.7	81.6	221.2	245.7	268.2	312.0	185.6	201.5	190.6	194.6	200.5	268.7	99.7	142.3	307.9	546.1	341.1	330.1	473.4	233.5	241.8	443.4
PTGS1	"COX1, PGHS-1, PTGHS"	ENSG00000095303	"Prostaglandin-endoperoxide synthase 1"	P23219	9	122370530-122395703	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 211.4;urinary bladder: 163.9"	"Cell type enriched"	"Detected in many"	4	"granulocytes: 205.3"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 53.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 13.0;granulocytes: 14.4;monocytes: 8.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 28.8;ASC TERT1: 22.8;BJ: 27.9;BJ hTERT+: 38.1;HEL: 17.5;HMC-1: 74.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002834, CAB020315"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		25000000	"Golgi apparatus"	Vesicles	"CAB020315: , HPA002834: AB_1079711"	"unprognostic (4.20e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (9.35e-4)"	4.5	1.1	1.8	9.1	3.1	2.6	2.5	0.5	2.7	2.6	35.3	4.6	3.0	3.9	2.5	1.6	25.7	16.7	9.4	4.9	1.9	1.6	3.9	1.8	4.0	1.4	3.5	0.7	3.6	1.0	0.7	2.4	0.8	2.5	60.9	9.3	1.5	1.9	2.3	0.7	55.9	6.5	211.4	4.9	3.6	7.8	1.0	3.1	0.4	1.5	5.3	4.2	163.9	19.5	2.5	13.0	14.4	8.5	1.9	0.1	13.7	0.0	0.1	0.1	0.0	28.8	22.8	0.0	27.9	38.1	0.2	0.2	0.0	0.0	1.0	1.3	4.7	0.0	1.7	0.1	2.5	0.2	0.0	0.0	17.5	0.1	0.0	8.3	1.2	74.3	11.6	0.3	1.4	0.0	0.0	10.3	0.0	0.0	0.0	0.5	0.0	0.0	1.5	0.4	0.0	0.1	0.0	0.3	2.0	3.6	0.0	0.1	0.1	0.1	2.3	0.0	0.1	0.0	2.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	7.6	0.0	12.0	7.6	14.4	0.0	8.5	0.0	1.7	0.0	0.0	13.0	2.5	0.0	0.0	3.5	1.9	6.1	0.9	0.1	13.7	1.8	3.1	0.5	2.7	1.9	1.6	3.5	0.7	2.5	3.1	0.0	10.0	0.9	2.4	8.9	0.0	1.1	0.0	1.4	2.3	40.1	0.0	0.1	0.0	0.5	0.0	6.0	0.0	0.0	0.4	0.2	4.7	1.9	205.3	0.0	25.3	0.0	1.7	36.8	10.7	0.0	1.4	22.9	3.3	4.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	51.3	0.3	0.7	0.5	0.6
PTGS2	COX2	ENSG00000073756	"Prostaglandin-endoperoxide synthase 2"	P35354	1	186671791-186680427	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"ductus deferens: 324.6;seminal vesicle: 377.9"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 318.6;Glandular cells: 122.9;granulocytes: 329.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"neutrophil: 12.8"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 12.8"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 95.4"	"Region enhanced"	"Detected in many"		"hippocampal formation: 16.5"	"Low region specificity"	"Detected in all"			"CAB000113, HPA001335"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"CAB000113: , HPA001335: AB_1079712"	"unprognostic (1.36e-3)"	"unprognostic (9.97e-3)"	"unprognostic (3.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.96e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (8.04e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.74e-2)"	5.7	2.1	1.2	3.7	1.1	32.6	1.5	0.8	1.9	21.1	11.4	1.1	324.6	0.4	2.3	1.8	1.7	4.0	9.5	9.1	1.1	1.0	3.3	2.7	22.1	2.3	1.3	0.8	1.6	0.4	3.1	2.2	2.5	1.9	9.2	2.7	3.9	0.9	377.9	1.0	1.1	2.4	7.7	4.7	0.9	11.4	1.0	0.9	0.6	1.5	3.4	1.3	17.3	1.9	0.0	0.5	12.8	0.8	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.6	0.5	0.0	21.8	95.4	0.1	0.8	3.4	4.0	0.0	0.0	0.1	0.6	2.9	0.0	1.7	0.3	0.0	0.0	0.2	0.5	0.0	3.2	0.0	0.1	0.2	0.6	2.7	6.9	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.2	0.0	0.2	0.6	0.0	0.1	0.3	4.6	0.1	3.2	0.1	0.0	0.0	0.0	6.7	0.1	0.5	0.0	0.4	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.8	0.0	0.4	0.0	0.0	0.0	1.2	1.1	0.8	1.9	1.1	1.0	1.3	0.8	1.9	0.9	318.6	102.3	0.5	47.5	105.6	0.0	1.9	0.0	8.1	53.4	0.0	0.0	0.1	0.0	0.8	0.2	14.3	0.0	0.0	0.2	0.2	36.1	122.9	329.1	0.0	11.5	0.0	1.2	6.7	16.5	0.0	0.0	112.3	33.7	0.0	0.5	0.0	3.2	0.0	0.0	0.0	0.2	0.0	21.7	0.1	0.4	24.8	0.5	0.0	1.3	107.5
SLC27A2	"ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS"	ENSG00000140284	"Solute carrier family 27 member 2"	O14975	15	50182196-50236395	"Enzymes, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 168.1"	"Cell type enhanced"	"Detected in many"	15	"Cytotrophoblasts: 236.8;Hepatocytes: 188.9;Proximal tubular cells: 112.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 49.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	27	"basophil: 27.3"	"Lineage enriched"	"Detected in many"	27	"granulocytes: 27.3"	"Cell line enhanced"	"Detected in many"		"A549: 17.9;HaCaT: 32.2;HL-60: 23.1;OE19: 36.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"hippocampal formation: 2.5"	HPA026089	Enhanced					NA	NA					"HPA026089: AB_1857060"	"unprognostic (3.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.38e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.48e-6)"	"unprognostic (5.01e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (6.40e-4)"	1.1	8.1	0.7	4.1	0.8	1.2	3.4	1.5	1.0	0.5	4.2	0.4	1.3	2.5	0.2	17.5	1.2	2.6	1.3	0.2	1.1	1.1	39.4	168.1	1.7	0.8	0.3	1.0	0.7	6.3	2.0	10.4	7.4	3.0	1.2	4.0	3.2	0.6	0.3	0.2	0.6	5.3	0.1	0.3	0.4	0.4	0.7	0.1	0.1	1.0	0.2	1.3	1.4	0.8	0.1	0.0	27.3	0.0	1.0	0.5	0.2	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.5	9.3	2.5	0.0	0.2	0.4	0.2	32.2	8.2	0.2	0.8	12.6	10.1	13.2	16.6	8.3	0.1	23.1	9.5	0.0	0.7	0.0	0.0	0.0	0.0	6.1	4.0	0.0	0.0	2.9	0.6	15.6	0.6	36.0	0.6	0.0	0.0	0.6	1.7	16.3	14.9	0.9	3.1	0.4	0.0	0.4	1.7	8.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	27.3	0.0	0.4	0.4	0.0	0.4	0.1	0.4	0.4	0.0	0.1	0.1	0.1	0.2	1.0	0.0	0.0	0.5	0.2	0.7	0.8	1.5	1.0	1.1	1.1	0.3	1.0	3.0	0.1	0.0	0.6	0.9	0.8	0.9	0.7	0.3	0.0	54.9	6.8	8.7	0.0	236.8	10.0	0.3	0.4	0.1	20.6	0.0	1.7	2.6	0.0	1.8	5.8	188.9	14.3	1.6	4.1	3.7	2.5	0.0	0.3	0.1	0.0	0.0	18.6	0.5	1.6	28.1	0.0	112.0	1.5	0.0	0.1	1.8	2.5	0.3	45.9	4.3	21.1	4.4
